293 related articles for article (PubMed ID: 23846297)
1. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
5. Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer.
Wang W; Zhang M; Sun W; Yang S; Su Y; Zhang H; Liu C; Li X; Lin L; Kim S; Okunieff P; Zhang Z; Zhang L
PLoS One; 2013; 8(10):e74272. PubMed ID: 24204567
[TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
7. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
9. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
10. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
11. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
15. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
16. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
Li W; Zhang C; Chen C; Zhuang G
Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
[TBL] [Abstract][Full Text] [Related]
17. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
[TBL] [Abstract][Full Text] [Related]
18. DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells.
Yu W; Xu YC; Tao Y; He P; Li Y; Wu T; Zhu YP; Li J; Wu JX; Dai J
Oncol Rep; 2013 Dec; 30(6):2741-8. PubMed ID: 24101127
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
